UPB Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
773.0K
-25.2%
1.0M
+54.8%
668.0K
-2.2%
683.0K
-27.1%
937.0K
Cost of Revenue
0
0
0
0
0
Gross Profit
773.0K
-25.2%
1.0M
+54.8%
668.0K
-2.2%
683.0K
-27.1%
937.0K
Operating Expenses
43.1M
-3.4%
44.6M
-4.7%
46.8M
+21.6%
38.5M
-14.9%
45.3M
R&D
36.1M
-1.3%
36.6M
-9.0%
40.2M
+21.8%
33.0M
-12.9%
37.9M
SG&A
7.1M
-12.8%
8.1M
+21.3%
6.7M
+20.3%
5.5M
-25.3%
7.4M
Operating Income
-42368000
+2.9%
-43615000
+5.5%
-46167000
-22.0%
-37834000
+14.7%
-44347000
EBITDA
-42318000
+2.9%
-43566000
+5.5%
-46110000
-22.0%
-37788000
+14.7%
-44305000
Net Income
-39702000
+2.2%
-40591000
+4.4%
-42459000
-25.8%
-33748000
+15.6%
-39966000
EPS (Basic)
$-0.73
+2.7%
$-0.75
+3.8%
$-0.78
-23.8%
$-0.63
+14.9%
$-0.74
EPS (Diluted)
$-0.73
+2.7%
$-0.75
+3.8%
$-0.78
-23.8%
$-0.63
+14.9%
$-0.74
Shares (Diluted)
54.6M
+0.4%
54.3M
+0.4%
54.1M
+0.3%
53.9M
+0.3%
53.8M
Upstream Bio (UPB) โ€” Financials